129 filings
Page 4 of 7
8-K
o94541ne8k36 ds7c
14 Sep 20
Regulation FD Disclosure
8:00am
8-K
3uzer3bqanoo7jd9q0
1 Sep 20
Sun BioPharma, Inc. Announces Pricing of $10.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:12pm
8-K
2g2 9x98p7noe41vj7
11 Aug 20
Sun BioPharma, Inc. Provides Business Update and Reports Q2 2020 Financial Results
8:15am
8-K
t44fviktz 1v
16 Jul 20
Sun BioPharma, Inc. Appoints Jennifer K. Simpson, Ph.D., as President and CEO
8:02am
8-K
s0uhs3lpl2iy
30 Jun 20
Sun BioPharma, Inc. Receives FDA Fast Track Designation for SBP-101
4:16pm
8-K
p7h 1iqji
19 Jun 20
Entry into a Material Definitive Agreement
8:00am
8-K
1kgzy7
11 Jun 20
Entry into a Material Definitive Agreement
4:16pm
8-K
zxwqsjlooij8p 5ynqq6
26 May 20
Departure of Directors or Certain Officers
11:47am
8-K
vfldsqdldfo
12 May 20
Sun BioPharma, Inc. Provides a Business Update and Reports Q1 2020 Financial Results
4:30pm
8-K
c98483a
3 Apr 20
Sun BioPharma Announces Pause in Enrollment of Clinical Trial of
4:47pm
8-K
ufyb4 xjkt2
24 Mar 20
Sun BioPharma Provides Business Update and Reports Operating Results for FY2019
8:19am
8-K
6df3d
28 Jan 20
Departure of Directors or Certain Officers
8:30am
8-K
afnb 5xoq
24 Jan 20
Sun BioPharma, Inc. Summarizes SBP-101 Phase 1 Clinical Data Presented at ASCO 2020 Annual Gastrointestinal Cancers Symposium
3:00pm
8-K
tgdonxw
20 Dec 19
Departure of Directors or Certain Officers
9:00am
8-K
i4sinr x9pxqt
13 Nov 19
Sun BioPharma, Inc. Provides a Business Update and Reports Q3 2019 Financial Results
8:15am
8-K
d33rrk6b7an3ig1q 1i1
9 Oct 19
Entry into a Material Definitive Agreement
4:15pm
8-K
1ek50voq rx
25 Sep 19
Entry into a Material Definitive Agreement
9:30am
8-K
wpy57l72t2 a8pgt
6 Sep 19
Entry into a Material Definitive Agreement
4:17pm
8-K
vvwwrwvkb6uvaoqdk 0t
29 Aug 19
Entry into a Material Definitive Agreement
5:03pm
8-K
5v2f48 eu1q
13 Aug 19
Sun BioPharma, Inc. Provides a Business Update and Files Report for Q2 2019
7:32am